HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market Intelligence

Set Alert for Market Intelligence

Health And Wellness Trademark Review 30 June, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Trademarks OTC Drugs

US FDA Wants To Improve Communication, Education On Supplements, Cosmetics

Supplement industry stakeholders say proposal could reveal helpful information about consumers’ regard for VMS products. But until the questions FDA will ask in interviews are known, it’s not clear whether the information collection might sow doubt about the products.

Market Intelligence United States

Italy's Supplements Market Gets Big Boost From COVID After Solid 2019

Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year. The strong start to 2020 builds on a solid 2019 for the Italian supplements market.

Italy Dietary Supplements

Stada's Nature’s Aid Submits CBD Novel Food Application

HBW Insight speaks exclusively to Chris Morrey, CEO of Stada's UK Nature's Aid subsidiary, about the company's experiments with CBD and its recently submitted EU novel food application. 

Wellness Dietary Supplements

COVID-19 Drives A Third Of French Consumers Towards Food Supplements

COVID-19 has accelerated a consumer trend towards taking daily food supplements and trying natural health products in France, a recent Synadiet survey finds. 

Wellness Dietary Supplements

Drug Quality Focus On Asia, OTCs Supported By US FDA's Second GMP Data Report

OTCs and other "no-application" products remain a drag on overall quality, agency finds in annual quality report, while India and China continue to pose challenges.

OTC Drugs FDA
See All
UsernamePublicRestriction

Register